(ORCL) Oracle - NYSE
Sector: Technology | Industry: Software - Infrastructure | Exchange: NYSE (USA) | Market Cap: 529.480m USD | Total Return: -7.8% in 12m
Avg Turnover: 4.94B
EPS Trend: 94.2%
Qual. Beats: 0
Rev. Trend: 96.9%
Qual. Beats: 0
Warnings
High Debt while negative Cash Flow
Altman Z'' 0.99 < 1.0 - financial distress zone
Fakeout
Tailwinds
No distinct edge detected
Oracle Corporation (NYSE: ORCL) is a global provider of enterprise information technology solutions, specializing in cloud-based software as a service (SaaS) and infrastructure technologies. Its product suite includes enterprise resource planning (ERP), supply chain management (SCM), and human capital management (HCM) through platforms like Oracle Fusion and NetSuite. The company also maintains a significant presence in database management with Oracle Database and MySQL, alongside infrastructure services such as cloud compute, storage, and networking.
Operating within the systems software sub-industry, Oracle utilizes a high-margin recurring revenue model driven by cloud license support and software subscriptions. The enterprise software sector is characterized by high switching costs, as integrated ERP and database systems often become deeply embedded in a clients core operational workflow. Beyond software, Oracle provides engineered hardware systems and consulting services to government agencies, educational institutions, and private enterprises.
For a more detailed analysis of these fundamentals, consider exploring the data available on ValueRay.
- Cloud infrastructure revenue growth accelerates through AI training and inference demand
- Oracle Fusion and NetSuite ERP expansion drives high-margin recurring subscription revenue
- Strategic cloud partnerships with Azure and Google expand database market reach
- High capital expenditure requirements for data center expansion pressure short-term free cash flow
- Integration of Oracle Health and Cerner optimizes vertical software revenue streams
| Net Income: 17.1b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.09 > 0.02 and ΔFCF/TA -8.81 > 1.0 |
| NWC/Revenue: 7.13% < 20% (prev -14.05%; Δ 21.18% < -1%) |
| CFO/TA 0.12 > 3% & CFO 32.0b > Net Income 17.1b |
| Net Debt (143b) to EBITDA (32.1b): 4.45 < 3 |
| Current Ratio: 1.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.92b) vs 12m ago 1.53% < -2% |
| Gross Margin: 65.81% > 18% (prev 70.51%; Δ -4.70% > 0.5%) |
| Asset Turnover: 31.32% > 50% (prev 34.09%; Δ -2.77% > 0%) |
| Interest Coverage Ratio: 5.25 > 6 (EBIT TTM 24.2b / Interest Expense TTM 4.60b) |
| A: 0.02 (Total Current Assets 46.6b - Total Current Liabilities 41.8b) / Total Assets 262b |
| B: -0.03 (Retained Earnings -7.09b / Total Assets 262b) |
| C: 0.11 (EBIT TTM 24.2b / Avg Total Assets 215b) |
| D: 0.20 (Book Value of Equity 43.1b / Total Liabilities 219b) |
| Altman-Z'' = 0.99 = BB |
| DSRI: 1.03 (Receivables 10.4b/8.56b, Revenue 67.4b/57.4b) |
| GMI: 1.07 (GM 70.51% / 65.81%) |
| AQI: 0.55 (AQ_t 0.33 / AQ_t-1 0.60) |
| SGI: 1.17 (Revenue 67.4b / 57.4b) |
| TATA: -0.06 (NI 17.1b - CFO 32.0b) / TA 262b) |
| Beneish M = -3.08 (Cap -4..+1) = AA |
As of June 16, 2026, the stock is trading at USD 192.64 with a total of 19,812,025 shares traded.
Over the past week, the price has changed by -9.05%,
over one month by -0.16%,
over three months by +23.94% and
over the past year by -7.83%.
Oracle has received a consensus analysts rating of 4.13. Therefore, it is recommended to buy ORCL.
- StrongBuy: 20
- Buy: 4
- Hold: 15
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 256 | 32.9% |
P/E Trailing = 31.524
P/E Forward = 25.0627
P/S = 7.8608
P/B = 13.4437
P/EG = 1.0147
Revenue TTM = 67.4b USD
EBIT TTM = 24.2b USD
EBITDA TTM = 32.1b USD
Long Term Debt = 125b USD (from longTermDebt, two quarters ago)
Short Term Debt = 7.20b USD (from shortTermDebt, last quarter)
Debt = 175b USD (from shortLongTermDebtTotal, last quarter) + Leases 18.5b
Net Debt = 143b USD (calculated: Debt 175b - CCE 31.9b)
Enterprise Value = 672b USD (529b + Debt 175b - CCE 31.9b)
Interest Coverage Ratio = 5.25 (Ebit TTM 24.2b / Interest Expense TTM 4.60b)
EV/FCF = -28.38x (Enterprise Value 672b / FCF TTM -23.7b)
FCF Yield = -3.52% (FCF TTM -23.7b / Enterprise Value 672b)
FCF Margin = -35.16% (FCF TTM -23.7b / Revenue TTM 67.4b)
Net Margin = 25.37% (Net Income TTM 17.1b / Revenue TTM 67.4b)
Gross Margin = 65.81% ((Revenue TTM 67.4b - Cost of Revenue TTM 23.0b) / Revenue TTM)
Gross Margin QoQ = 65.18% (prev 64.56%)
Tobins Q-Ratio = 2.57 (Enterprise Value 672b / Total Assets 262b)
Interest Expense / Debt = 2.63% (Interest Expense 4.60b / Debt 175b)
Taxrate = 12.59% (2.47b / 19.6b)
NOPAT = 21.1b (EBIT 24.2b * (1 - 12.59%))
Current Ratio = 1.12 (Total Current Assets 46.6b / Total Current Liabilities 41.8b)
Debt / Equity = 4.06 (Debt 175b / totalStockholderEquity, last quarter 43.1b)
Debt / EBITDA = 4.45 (Net Debt 143b / EBITDA 32.1b)
Debt / FCF = -6.03 (negative FCF - burning cash) (Net Debt 143b / FCF TTM -23.7b)
Total Stockholder Equity = 33.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.95% (Net Income 17.1b / Total Assets 262b)
RoE = 50.38% (Net Income TTM 17.1b / Total Stockholder Equity 33.9b)
RoCE = 15.23% (EBIT 24.2b / Capital Employed (Equity 33.9b + L.T.Debt 125b))
RoIC = 9.43% (NOPAT 21.1b / Invested Capital 224b)
WACC = 10.07% (E(529b)/V(704b) * Re(12.64%) + D(175b)/V(704b) * Rd(2.63%) * (1-Tc(0.13)))
Discount Rate = 12.64% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 86.67 | Cagr: 1.50%
[DCF] Fair Price = unknown (Cash Flow -23.7b)
EPS Correlation: 94.17 | EPS CAGR: 12.88% | SUE: 0.73 | # QB: 0
Revenue Correlation: 96.91 | Revenue CAGR: 10.00% | SUE: 0.69 | # QB: 0
EPS current Quarter (2026-08-31): EPS=1.72 | Chg30d=+2.54% | Revisions=+0% | Analysts=33
EPS next Quarter (2026-11-30): EPS=1.88 | Chg30d=+2.57% | Revisions=+33% | Analysts=33
EPS current Year (2027-05-31): EPS=8.03 | Chg30d=+0.06% | Revisions=+40% | GrowthEPS=+5.3% | GrowthRev=+32.1%
EPS next Year (2028-05-31): EPS=10.88 | Chg30d=+1.60% | Revisions=-9% | GrowthEPS=+35.5% | GrowthRev=+45.7%
[Analyst] Revisions Ratio: +40%